Eptifibatide Injection, Solution
Product Images NDC 72078-026

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eptifibatide (NDC 72078-026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

Chemical structure diagram of eptifibatide, showing its molecular components including peptide bonds, disulfide bridge, and various functional groups, consistent with the active ingredient in Eptifibatide injection solution.*

FDA Label Image

Figure 2 (Image 02)

A line graph depicting the percent of patients with events over time (days) comparing Eptifibatide treatment and placebo. The y-axis shows the percent of patients with events, and the x-axis shows time in days up to 30 days. Two lines represent Eptifibatide (solid line) and placebo (dashed line), illustrating differences in event rates over the period.*

FDA Label Image

Carton 20 mg (Image 03)

Packaging label for Eptifibatide Injection, 20 mg/10 mL (2 mg/mL) intravenous injection solution. The label indicates a single-dose vial for weight-adjusted bolus dosing, sterile and Rx only. Manufactured for Mylan Institutional LLC. Storage instructions and contents details are provided, with branding by Novaplus.*

FDA Label Image

Carton 75 mg (Image 04)

Packaging label for Eptifibatide Injection 75 mg/100 mL (0.75 mg/mL) intravenous solution, single-dose vial. Label includes dosage strength, storage instructions, contents with active and inactive ingredients, manufacturer as Mylan Institutional LLC, and barcode. The label is predominantly purple and yellow with the Novaplus logo.*

FDA Label Image

Carton 200 mg (Image 05)

Packaging label for Eptifibatide Injection 200 mg/100 mL (2 mg/mL) intravenous injection solution. The label indicates a single-dose sterile vial for intravenous use, manufactured for Mylan Institutional LLC. Storage instructions and contents per mL are detailed, including 2 mg eptifibatide and 5.25 mg citric acid. The product is noted as Rx only and marked with the Novaplus branding.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.